Status:
COMPLETED
Targeted Screening of At-Risk Adults for Acute HIV-1 Infection
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
International AIDS Vaccine Initiative
KEMRI-Wellcome Trust Collaborative Research Program
Conditions:
HIV
Eligibility:
All Genders
18-29 years
Phase:
NA
Brief Summary
In this research, the investigators want to see if early detection of HIV infection can be improved by testing young adults who seek urgent health care from pharmacies and healthcare facilities with s...
Eligibility Criteria
Inclusion
- symptom score of 2 or more: Confirmed fever (≥37.5 °C axillary), reported diarrhoea, or evidence of STD (variable score=2); reported body pains, or report of more than one sexual partners in past 2 months (variable score=1)
- resident in Mtwapa or Shanzu or planning to stay in Mtwapa for approximately 4 weeks duration
- willing to give locator information (including mobile phone number)
- negative or unknown HIV status
Exclusion
- patients not meeting inclusion criteria
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
522 Patients enrolled
Trial Details
Trial ID
NCT01876199
Start Date
February 1 2013
End Date
July 1 2013
Last Update
August 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KEMRI Mtwapa
Kilifi, Kenya, 80108